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ABSTRACT 
Objective: To isolate and identify the bioactive metabolites from the culture filtrates of a bacterium (Bacillus cereus) symbiotically associated with a 
novel entomopathogenic nematode Rhabditis (Oscheius) species. 
Methods: The bacterium was cultured in three different media and the antimicrobial activity was determined by the well diffusion assay. The ethyl 
acetate extract of the cell free culture filtrate was then purified by silica gel column chromatography and thin layer chromatography. Identification 
of the active metabolite was done with HPLC, GC-MS and LC-MS. 
Results: The cell free culture filtrate of a nematode symbiotic bacterium showed both antibacterial and antifungal activities. Fermentation 
conditions were standardized and optimum antibacterial activity was observed in tryptic soy broth at 72 h of incubation at 30 °C. When the ethyl 
acetate extract was purified by silica gel column chromatography and thin layer chromatography, an active fraction was obtained which was 
subjected to HPLC analysis along with GC-MS and LC-MS leading to the identification of a major compound Bis (2-ethyl hexyl) phthalate. The 
compound was active against Gram positive bacteria Bacillus subtilis MTCC2756, Staphylococus aureus MTCC902, Gram negative bacteria 
Escherichia coli MTCC 2622 and fungi such as Aspergillus flavus MTCC277, Candida albicans MTCC183, Fusarium oxysporum MTCC 284, Rhizoctonia 
solani MTCC 4634. 
Conclusion: Bis (2-ethyl hexyl) phthalate was identified as one of the metabolites produced by a nematode symbiotic bacterium associated with a 
novel entomopathogenic nematode Rhabditis (Oscheius) species. Thus similar compounds isolated from novel entomopathogenic bacteria would 
pave the way for identifying new drugs for the pharmaceutical and agricultural sector.  
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INTRODUCTION 
Keeping the health care sector is one of the most urgent needs for 
humankind. One of the greatest concerns is the increasing frequency of 
reports of the development of resistance to drugs by many bacterial 
pathogens, and this is resulting in the lives of many patients being in 
danger. The emergence and rapid dissemination of infectious agents 
resistant to antibiotic treatments have emphasized the need for 
alternate chemicals [1]. After 50 years of intensive research on 
secondary metabolites from microorganisms, studies on new 
antibiotics and anti-tumor agents are still a hot topic of research.  
Xenorhabdus and Photorhabdus, the symbiotic bacteria associated 
with entomopathogenic nematodes (EPN) steinernematidae and 
heterorhabditidae respectively are considered as goldmines for 
pharmacologically active secondary metabolites. Research has 
proved the antibacterial [2], antifungal [3, 4], nematicidal [5, 6] and 
insecticidal effects [7] of these bacteria.  
Recent studies on entomopathogenic nematodes for biocontrol of 
insects at Central Tuber Crops Research Institute (CTCRI) paved the 
way for the identification of a new entomopathogenic nematode sp. 
namely Rhabditis (Oscheius) sp. [8] and their symbiotic bacteria. 
Sequence analysis of the D2-D3 expansion fragments of the 28S rDNA 
of the nematode isolate B (Accession no. CTCRI/EPN/03, NCBI deposit 
No HM474857) used in the present study by Deepa et al. [9] showed 
90% similarity at the nucleotide level with that of Rhabditis sp. 
Tumian., 2007 (Accession No EU273599.1). The bacteria associated 
with this nematode isolate (NCBI deposit No HQ200405) showed 
100% sequence similarity with Bacillus cereus biovar anthracis, strain 
CI (CP 001746) [10]. This study was designed to purify and identify 
the antimicrobial metabolite from this particular bacterial strain B, the 
crude culture of which exhibited high antimicrobial activity. This is the 
first report on the antimicrobial activities of Bis (2-ethyl hexyl) 
phthalate isolated from symbiotic bacteria associated with the 
entomopathogenic nematode Rhabditis (Oscheius) sp.  
MATERIALS AND METHODS 
Chemicals and media  
All chemicals used in the study were of analytical grade. Silica gel 
powder, silica gel plates F 254 and the solvents such as hexane, 
dichloromethane, ethyl acetate, methanol, benzene, chloroform, 
acetone, HPLC grade methanol etc were purchased from Merck 
Specialities Private Limited, Mumbai, India. Microbiological media 
and the standard antibiotic (ciprofloxacin) discs were purchased 
from Himedia Laboratories Private limited, Mumbai, India.  
Test organisms and maintenance 
The test organisms namely Bacillus subtilis MTCC2756, 
Staphylococus aureus MTCC902 and Escherichia coli MTCC 2622 
were obtained from Microbial Type Culture Collection & Genebank, 
Institute of Microbial Technology (IMTECH), Chandigarh, and were 
subcultured on nutrient agar once in a month. The test fungi such as 
Aspergillus flavus MTCC277, Candida albicans MTCC183, Fusarium 
oxysporum MTCC 284, Rhizoctonia solani MTCC 4634 and Penicillium 
expansum MTCC 2006 were also obtained from IMTECH and 
maintained on potato dextrose agar. 
Isolation of bacteria from the entomopathogenic nematodes 
One nematode isolate of Rhabditis (Oscheius) sp. (Accession no. 
CTCRI/EPN/03, NCBI deposit No HM474857) is selected from 65 
isolates maintained at CTCRI. The bacterial strain B was isolated 
from the third stage infective juveniles of the nematode using the 
following protocol. The nematodes were surface sterilized by 
putting them in streptomycin solution (5000 units/ml) for one hour 
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and washing it in distilled water thrice for 20 min, 10 min and 5 min 
respectively. These were transferred to nutrient broth and kept in 
shaker overnight. The nutrient broth was streaked on nutrient agar 
to get pure culture and it was subsequently subcultured once in two 
weeks and stored. For the consecutive studies, the bacterium was 
taken from this culture collection maintained in the CTCRI 
laboratory.  
Screening the bacterial culture filtrate for antimicrobial activity 
Newly subcultured bacteria were inoculated into 100 ml of Tryptic 
Soy Broth (TSB) and kept at 30 °C and 150 rpm overnight. This 
culture (with an optical density of 1.5) was used to inoculate 400 ml 
of TSB and incubated for 72 h in the same conditions. The optical 
density of the culture was checked. The culture was centrifuged at 
10,000 rpm for 10 min at 4 °C to get cell free culture filtrate. It was 
concentrated to 5 ml with a rotary evaporator and stored at-20 °C 
for antimicrobial assay.-20 °C 
Assay of antibacterial activity 
The test bacteria maintained on nutrient agar were inoculated into 
10 ml of nutrient broth and incubated at 37 °C for 18 h. This 
culture was used to inoculate on Mueller Hinton Agar (MHA) 
plates with a sterile cotton swab. Wells was punched (6 mm 
diameter) in the agar and filled with 50 µl of samples. Commercial 
antibiotic Ciprofloxacin (1 µg/ml, Himedia) was used as positive 
reference standard to determine the sensitivity of the strains. 
Plates were incubated at 37 °C for 24 h. Antibacterial activity was 
evaluated by measuring the diameter of the inhibition zone. The 
mean of 3 values was recorded.  
Assay of antifungal activity 
Using a cotton swab, the potato dextrose agar surfaces were 
uniformly swabbed with the fungal cultures and wells were punched 
(6 mm diameter) in the agar and filled with 50 µl of samples. 
Commercial fungicide Bavistin (100 µg/ml) was used as positive 
reference standard to determine the sensitivity of the strains. The 
treatments and control were each replicated three times. After 48 h 
in the dark at 25 °C, the area of the inhibition zone was calculated 
based on the average of two diameters measured in two 
perpendicular directions. 
Standardization of fermentation of the bacteria for maximum 
activity and extraction of metabolites with an organic solvent 
The mother culture was prepared by inoculating the bacteria into 2 
sets of 250 ml flasks each containing 100 ml of Tryptic Soy broth 
(TSB), Luria Bertani broth (LB) and Nutrient broth (NB) and kept at 
30 °C and 150 rpm for 24 h incubation. This 24 h mother culture 
(with an optical density of 1.5) was used to inoculate 2 flasks each 
containing 400 ml each of TSB, LB and NB respectively. 
Fermentation was allowed to carry out for different time intervals 
such as 24 h, 48 h, 72 h, 96 h and 120 h. The culture was centrifuged 
at 10,000 rpm for 15 min at 4 °C and to the supernatant; half the 
volume of ethyl acetate was added. The flask was swirled slowly and 
allowed both fractions to separate out. To the aqueous fraction, 
again half the volume of ethyl acetate was added and allowed the 
fractions to separate out completely. The organic fraction was 
concentrated with a rotary evaporator and the concentrate was 
dissolved in 1 ml of methanol. This was assayed for antibacterial and 
antifungal activities. 
Purification of the bioactive metabolites from the organic fraction 
The initial studies of the purification of the organic fraction were 
carried out with thin layer chromatography (TLC). The crude 
organic fractions were spotted on TLC plates (Silica gel 60 F254, 
Merck). The different solvent systems such as Hexane: Ethyl acetate 
(80:20), Hexane: Ethyl acetate (60:40), Ethyl acetate: Methanol: 
water (100:13.5:10) were tried. The developed TLC plate was 
visualized at 254 nm (short UV) and 365 nm (long UV). 
Column chromatography  
The 72 h TSB culture broth (30 l) obtained after centrifugation was 
extracted twice with ethyl acetate and concentrated under vacuum 
to yield a crude extract (10 g), which was then subjected to silica gel 
column (60 cm long, and 3.0 mm in diameter)` for further 
purification. The column was eluted with a gradient of solvent 
mixtures of increasing polarity starting from a non polar solvent 
such as hexane, followed by mixtures of dichloromethane in hexane 
(5%-100%), ethyl acetate in dichloromethane (1%-100%), finally 
with methanol/ethylacetate (1%-100%). 25 ml fractions were 
collected and were concentrated using a rotary evaporator. The 
purity of different fractions was checked by TLC (Silica gel 60 F254, 
Merck) and similar fractions were pooled and assayed for 
antibacterial and antifungal activities. The fractions showing strong 
antimicrobial activity were further subjected to preparative TLC in 
benzene: hexane (3:1) solvent system to increase the purity. 
Identification of the active substance by analytical methods 
Liquid Chromatography/Mass Spectophotometry (LC/MS)  
In order to identify the active compound, LC/MS was carried out on 
C18 column (100x4.6 mm, 3 um) with 100% methanol as the mobile 
phase. The flow rate was adjusted as 1 ml/min and the mass range 
was 50-450 amu with positive mode of ionization. 
Gas Chromatography/Mass Spectophotometry (GC/MS) 
GC/MS analysis was carried out in a Varian CP 3800 interfaced to a 
Saturn 2200 mass spectrometer. The capillary GC column used was 
30 mm x 0.5 mm in dimension with 100% dimethyl polysiloxane as 
the packing material. The conditions were as follows: electron 
impact mode at an ionizing voltage 70 eV, scan range 40-600 amu, 
helium as the carrier gas at a constant flow of 1 ml/min and 
injection volume of 1 µl. The oven temperature was programmed 
from 100 °C to 270 °C (Isothermal for 1.5 minutes with an increase 
of 4 °C/min to 150 °C, then 5 °C/min to 270 °C, ending with 20 min 
isothermal at 270 °C). 
Confirmation of the compound by HPLC 
The suspected standard compound was purchased commercially 
(TCI chemicals, Chennai) and run an HPLC (C18column, 4.6X250 
mm) along with the sample for confirmation of the identity of the 
molecule. 
RESULTS AND DISCUSSION 
Screening the bacterial culture filtrate for antimicrobial activity 
In the present study, an attempt was made to purify the bioactive 
secondary metabolites from symbiotic bacteria associated with an 
entomopathogenic nematode. During the initial screening for the 
antimicrobial activity of the 72 h concentrated cell free culture 
filtrate, significant activities were recorded against the fungus 
Aspergillus flavus (10 mm diameter) and the bacteria Bacillus subtilis 
and Staphylococcus aureus (11 mm diameter each). The bacteria 
started to produce bioactive compounds from the end of exponential 
phase and reach its maximum in the stationery phase.  
Standardization of fermentation of the bacteria for maximum 
activity and extraction of metabolites with an organic solvent 
When the bacterial fermentation was standardized in three different 
media namely TSB, LB and NB for different time intervals starting 
from 24 h to 120 h, the maximum antibacterial activity was recorded 
in TSB medium at 72 h. This was followed by LB at 48h and very less 
activity was recorded in the case of NB (fig. 1. a-c). The antifungal 
activity was also shown to be the maximum in the case of TSB media 
at 72 h of fermentation (fig. 2. a-c).  
Recently Fang et al. [13] performed a comparison of TSB, LB, NB and 
other modified media in enhancing the antibiotic activity and found 
that TSB medium was found to be the optimum medium for biomass 
and antibiotic activity. Our results also confirmed the previous 
reports by Maxwell et al. [14] and Ji et al. [15] about the high 
productivity of TSB medium. Chen [16] suggested that the different 
media used may contribute to the different levels of activity 
expressed. There is a good correlation between the antibacterial and 
antifungal activity of the ethyl acetate fraction, so the same agent, 
which is ethyl acetate extractable, may be responsible for both 
activities as suggested by Chen [16]. 
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Fig. 1(a): The antibacterial activity of the three crude organic 
fractions against S. aureus 
 
 
Fig. 1(b): The antibacterial activity of the three crude fractions 
against E. coli 
 
 
Fig. 1(c): The antibacterial activity of the three crude fractions 
against B. subtilis 
 
 
Fig. 2(a): The antifungal activity of the three crude fractions 
against R. solani 
 
Fig. 2(b): The antifungal activity of the three crude fractions 
against Fusarium oxysporum 
 
 
Fig. 2(c): The antifungal activity of the three crude fractions 
against Penicillium expansum 
 
Purification of the bioactive metabolites from the organic fraction 
After standardization of the different media and time intervals, 
bacterial fermentation in tryptic soy broth (TSB) for 72 h was 
chosen because of its maximum antibacterial as well as antifungal 
activities. So this fermentation process was repeated several times 
to yield about 10 g of active oily organic residue from 30 l of culture 
broth for further purification by chromatographic methods. In order 
to get an idea about the number of compounds in the crude organic 
fraction and their polarity, an initial thin layer chromatogram was 
run with solvent systems such as hexane: ethyl acetate (80:20), 
hexane: ethyl acetate (60:40), ethyl acetate: methanol: water 
(10:1.35:0.1). Separation was found to be better when ethyl acetate: 
methanol: water (10:1.35:0.1) was used as a solvent. 
Silica gel column chromatography 
Initially the column was washed with hexane, followed by mixtures 
of dichloromethane (DCM) in hexane (5%-100%). The TLC was 
carried out with benzene: hexane (3:1) as the solvent system and 
similar fractions were pooled and concentrated.  
 
Fig. 3: Positive result for organic acid 
This was again subjected to preparative TLC to remove the 
impurities. The 75% to 100% DCM fraction eluted from the column 
showed significant antibacterial activity against B. subtilis and S. 
aureus and antifungal activity against A. flavus, C. albicans, F. 
oxysporum and R. solani (table 1). This fraction gave positive result 
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for the test for organic acid by dipping the chromatogram in a 
solution of 5 mg Bromo cresol green in 25 ml ethanol and 0.25 ml of 
0.1M NaOH. A yellow spot was obtained on a blue background 
(fig.3).
 
Table 1: The antimicrobial activity of the purified fraction against different test organisms 
Name of the test organism Zone diameter (mm) 
for 50 mg/well 
Standard antibiotic  
Bacillus subtilis 12 Ciprofloxacin (1µg)-21 mm  
Staphylococus aureus 12 Ciprofloxacin (1µg)-19 mm 
E. coli 11 Ciprofloxacin (1µg)-20 mm 
Aspergillus flavus 10 Bavistin (100 µg)-25 mm 
Candida albicans 11 Amphotericin (5 µg)-23 mm 
Fusarium oxysporum 10 Bavistin (100 µg)-16 mm 
Rhizoctonia solani 11 Bavistin (100 µg)-19 mm 
Values represent the mean of three replications 
 
Identification of the active substance by analytical methods 
Liquid Chromatography/Mass Spectophotometry (LC/MS)  
From the LC-MS data, it was clear that the major compound was 
having a mass of 391.3 a. m. u (fig. 4) 
 
 
Fig. 4: The Q1 MS of the major peak (391.3 amu) 
 
Gas Chromatography/Mass Spectophotometry (GC/MS)  
Partial purification by column chromatography followed by GC-MS 
and LC MS studies led to the identification of Bis (2 ethyl hexyl) 
phthalate (fig. 5) as a major antimicrobial compound. 
 
 
Fig. 5: The GC spectra of Bis (2-ethyl hexyl) phthalate 
Confirmation of the identity of the molecule by HPLC 
HPLC analysis of the purified compound showed that it eluted at a 
retention time of 6.3 which was comparable with that of standard 




Fig. 6: The HPLC profile of the standard 
 
 
Fig. 7: The HPLC profile of the sample 
 
Bis (2-ethyl hexyl) phthalate was identified as one of the metabolites 
produced by a nematode symbiotic bacterium associated with a 
novel entomopathogenic nematode Rhabditis (Oscheius) species. 
Phthalate compounds are petrochemicals used as plasticizers or 
solvents in a variety of industrial products. But many phthalate 
derivatives have been isolated from plants, fungi and bacteria. The 
first report on Bis (2-ethylhexyl) phthalate from microbial origin 
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was by Uyeda et al. [17] in Streptomyces sp. Bis (2-ethylhexyl) 
phthalate has also been reported as a bioactive compound from 
terrestrial and marine organisms including Streptomyces 
bangladeshiensis [18], Streptomyces mirabilis strain NSQu-25[19] 
Pseudomonas sp. PBO1 [20], marine algae [21-24], fungi [25] and 
Nocardia levis [26]. In the present study, this compound showed 
good antibacterial activity against B. subtilis, S. aureus and E. coli and 
antifungal activity against A. flavus, C. albicans, F. oxysporum similar 
to the reports by Kavitha et al [26] in Nocardia levis. Al Bari et al. 
[18] also reported that this compound shows a zone diameter of 15 
mm and 13 mm for B. subtilis, S. aureus respectively at a 
concentration of 30 mg/disc similar to the present study. This 
compound is considered as pro inflammatory agent in some studies 
[27, 28]. The same compound was isolated from the plant Aloe vera 
and was found to have antileukemic and antimutagenic effects [29].  
CONCLUSION 
Entomopathogenic nematodes (EPN) are well-known as biological 
control agents and are found to be associated with symbiotic 
bacteria which can produce a wide range of bioactive secondary 
metabolites. This study reports the antimicrobial activities of Bis (2-
ethylhexyl) phthalate from a symbiotic bacterium associated with 
the entomopathogenic nematode Rhabditis (Oscheius) species. 
Identification of the compounds reported here is preliminary and 
further structural analyses need to be performed to ascertain the 
identity of the compounds and to evaluate its potential as a drug 
molecule in the pharmaceutical and agriculture industry. 
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